These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17091247)

  • 21. Fcgamma receptors in the initiation and progression of systemic lupus erythematosus.
    Reefman E; Dijstelbloem HM; Limburg PC; Kallenberg CG; Bijl M
    Immunol Cell Biol; 2003 Oct; 81(5):382-9. PubMed ID: 12969326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.
    Shushakova N; Skokowa J; Schulman J; Baumann U; Zwirner J; Schmidt RE; Gessner JE
    J Clin Invest; 2002 Dec; 110(12):1823-30. PubMed ID: 12488432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fcgamma receptor polymorphisms and systemic lupus erythematosus].
    Brambila-Tapia AJ; Dávalos-Rodríguez IP
    Rev Invest Clin; 2009; 61(1):66-72. PubMed ID: 19507476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.
    Sondermann P
    J Clin Immunol; 2016 May; 36 Suppl 1():95-9. PubMed ID: 27039179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complex role of Fcgamma receptors in the pathology of arthritis.
    Boross P; Verbeek JS
    Springer Semin Immunopathol; 2006 Dec; 28(4):339-50. PubMed ID: 17043867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.
    Ben Mkaddem S; Benhamou M; Monteiro RC
    Front Immunol; 2019; 10():811. PubMed ID: 31057544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Damage-associated molecular patterns and their role as initiators of inflammatory and auto-immune signals in systemic lupus erythematosus.
    Álvarez K; Vasquez G
    Int Rev Immunol; 2017 Sep; 36(5):259-270. PubMed ID: 28961019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus.
    Tan Sardjono C; Mottram PL; Hogarth PM
    Immunol Cell Biol; 2003 Oct; 81(5):374-81. PubMed ID: 12969325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTLA4 gene variants in autoimmunity and cancer: a comparative review.
    Ghaderi A
    Iran J Immunol; 2011 Sep; 8(3):127-49. PubMed ID: 21931200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis.
    Clatworthy MR; Harford SK; Mathews RJ; Smith KG
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17971-6. PubMed ID: 25475856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into IL-37, the role in autoimmune diseases.
    Xu WD; Zhao Y; Liu Y
    Autoimmun Rev; 2015 Dec; 14(12):1170-5. PubMed ID: 26264940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders.
    Pope RM; Yoshinoya S; McDuffy SJ
    Clin Exp Immunol; 1981 Nov; 46(2):259-67. PubMed ID: 7337971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice.
    Tan Sardjono C; Mottram PL; van de Velde NC; Powell MS; Power D; Slocombe RF; Wicks IP; Campbell IK; McKenzie SE; Brooks M; Stevenson AW; Hogarth PM
    Arthritis Rheum; 2005 Oct; 52(10):3220-9. PubMed ID: 16200626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases.
    Recke A; Vidarsson G; Ludwig RJ; Freitag M; Möller S; Vonthein R; Schellenberger J; Haase O; Görg S; Nebel A; Flachsbart F; Schreiber S; Lieb W; Gläser R; Benoit S; Sárdy M; Eming R; Hertl M; Zillikens D; König IR; Schmidt E; Ibrahim S;
    J Autoimmun; 2015 Jul; 61():36-44. PubMed ID: 26032265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Addobbati C; de Azevêdo Silva J; Tavares NA; Monticielo O; Xavier RM; Brenol JC; Crovella S; Chies JA; Sandrin-Garcia P
    Ann Hum Genet; 2016 Jan; 80(1):1-6. PubMed ID: 26464189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis.
    Taylor RP; Lindorfer MA
    Nat Clin Pract Rheumatol; 2007 Feb; 3(2):86-95. PubMed ID: 17299446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
    Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
    Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.